Wolfgang Miesbach: CMA CAR-T Induces Immune Reset and Durable Remission in Refractory ITP – EHA 2026 Late-Breaking Update
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn about a recent article by Jinhui Shu et al, adding։
“Looking ahead to EHA 2026 next week, I am particularly interested in an upcoming late-breaking presentation:
- BCMA CAR-T Cell Therapy Induces Comprehensive Immune Resetting and Durable Remission in Refractory Primary Immune Thrombocytopenia
Targeting plasma cells and pathogenic antibody production represents a promising mechanistic shift beyond traditional B-cell–directed approaches.
It will be exciting to see how these strategies translate into clinical responses and immune modulation.”
Title: BCMA CAR-T cell therapy induces comprehensive immune resetting and durable remission in refractory primary immune thrombocytopenia
Authors: Jinhui Shu, Min Xu, Wei Xie, Lin Liu, Peiru Li, Hongjian Li, James Bussel, Yu Hu, Heng Mei
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 26, 2026, 01:48Rob Maloney: Why Global Diagnosis is the Missing Piece in Bleeding Disorder Care
-
Jul 26, 2026, 01:35Moustafa Abdou: Ehlers-Danlos Syndrome – Why Collagen Matters for Hemostasis
-
Jul 26, 2026, 01:25Vrisha Shah: Exploring Transgenic Mouse Models for Pregnancy Outcomes at ISTH 2026
-
Jul 26, 2026, 01:06Christine Bork: Why Misinformation Around a Single Vitamin Postpartum is Putting Babies at Risk
-
Jul 26, 2026, 00:44A Significant Step Forward For People With Bleeding Disorders In The Dominican Republic – WFH
-
Jul 25, 2026, 18:00The Evolving Landscape of Factor Replacement Therapy – EAHAD
-
Jul 25, 2026, 17:43Heghine Khachatryan: Advancing Care for Women and Girls With Hemophilia
-
Jul 25, 2026, 17:00Revathy R Menon: A Memorable Milestone at the 39th ISBT Congress
-
Jul 25, 2026, 16:19Nicola Potere: From Scientific Exchange to Global Collaboration at ISTH 2026